Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bryant

Showing results (461-470 of 474) with videos related to

Pageof 48
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|April 11, 2020
<sup>90</sup>Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's LymphomaKevin C Conlon, Claude Sportes, Martin W Brechbiel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset ExpansionKevin C Conlon, E Lake Potter, Stefania Pittaluga, et al.
Journal of the Neurological Sciences|July 31, 2021
Neurology trial registrations on ClinicalTrials.gov between 2007 and 2018: A cross-sectional analysis of characteristics, early discontinuation, and results reportingBrandon E Turner, Christopher J Magnani, Alexander Frolov, et al.
Blood|March 10, 2011
Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaquesThomas A Waldmann, Enrico Lugli, Mario Roederer, et al.
Journal of Neurotrauma|October 19, 2022
Neuroimaging Correlates of Post-Traumatic Stress Disorder in Traumatic Brain Injury: A Systematic Review of the LiteratureAaron I Esagoff, Daniel A Stevens, Natalia Kosyakova, et al.
Journal of the Academy of Consultation-Liaison Psychiatry|September 17, 2021
Neuroimaging Correlates of Syndromal Anxiety Following Traumatic Brain Injury: A Systematic Review of the LiteratureSahar Jahed, Nicholas O Daneshvari, Angela L Liang, et al.
Alimentary Pharmacology & Therapeutics|October 14, 2017
Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseasesN Mitrev, N Vande Casteele, C H Seow, et al.
Journal of Perinatal Medicine|February 5, 2021
Clinical chorioamnionitis at term X: microbiology, clinical signs, placental pathology, and neonatal bacteremia - implications for clinical careRoberto Romero, Percy Pacora, Juan Pedro Kusanovic, et al.
Journal of the Academy of Consultation-Liaison Psychiatry|May 26, 2022
Behavioral and Emotional Dyscontrol Following Traumatic Brain Injury: A Systematic Review of Neuroimaging and Electrophysiological CorrelatesBarry R Bryant, Lisa N Richey, Sahar Jahed, et al.
Cancer Cell|July 31, 2018
Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/LymphomaMasao Nakagawa, Arthur L Shaffer, Michele Ceribelli, et al.
Pageof 48

Showing results (461-470 of 474) with videos related to

Sort By:
Pageof 48
Cancer Biotherapy & Radiopharmaceuticals|April 11, 2020
<sup>90</sup>Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's LymphomaKevin C Conlon, Claude Sportes, Martin W Brechbiel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset ExpansionKevin C Conlon, E Lake Potter, Stefania Pittaluga, et al.
Journal of the Neurological Sciences|July 31, 2021
Neurology trial registrations on ClinicalTrials.gov between 2007 and 2018: A cross-sectional analysis of characteristics, early discontinuation, and results reportingBrandon E Turner, Christopher J Magnani, Alexander Frolov, et al.
Blood|March 10, 2011
Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaquesThomas A Waldmann, Enrico Lugli, Mario Roederer, et al.
Journal of Neurotrauma|October 19, 2022
Neuroimaging Correlates of Post-Traumatic Stress Disorder in Traumatic Brain Injury: A Systematic Review of the LiteratureAaron I Esagoff, Daniel A Stevens, Natalia Kosyakova, et al.
Journal of the Academy of Consultation-Liaison Psychiatry|September 17, 2021
Neuroimaging Correlates of Syndromal Anxiety Following Traumatic Brain Injury: A Systematic Review of the LiteratureSahar Jahed, Nicholas O Daneshvari, Angela L Liang, et al.
Alimentary Pharmacology & Therapeutics|October 14, 2017
Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseasesN Mitrev, N Vande Casteele, C H Seow, et al.
Journal of Perinatal Medicine|February 5, 2021
Clinical chorioamnionitis at term X: microbiology, clinical signs, placental pathology, and neonatal bacteremia - implications for clinical careRoberto Romero, Percy Pacora, Juan Pedro Kusanovic, et al.
Journal of the Academy of Consultation-Liaison Psychiatry|May 26, 2022
Behavioral and Emotional Dyscontrol Following Traumatic Brain Injury: A Systematic Review of Neuroimaging and Electrophysiological CorrelatesBarry R Bryant, Lisa N Richey, Sahar Jahed, et al.
Cancer Cell|July 31, 2018
Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/LymphomaMasao Nakagawa, Arthur L Shaffer, Michele Ceribelli, et al.
Pageof 48